Literature DB >> 28388710

FGFR-TACC approaches the first turn in the race for targetable GBM mutations.

Cameron Brennan1.   

Abstract

Mesh:

Year:  2017        PMID: 28388710      PMCID: PMC5464322          DOI: 10.1093/neuonc/nox005

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 2.  FGFR-TACC gene fusions in human glioma.

Authors:  Anna Lasorella; Marc Sanson; Antonio Iavarone
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 3.  Targeting FGFR Signaling in Cancer.

Authors:  Mehdi Touat; Ecaterina Ileana; Sophie Postel-Vinay; Fabrice André; Jean-Charles Soria
Journal:  Clin Cancer Res       Date:  2015-06-15       Impact factor: 12.531

4.  Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.

Authors:  David A Nathanson; Beatrice Gini; Jack Mottahedeh; Koppany Visnyei; Tomoyuki Koga; German Gomez; Ascia Eskin; Kiwook Hwang; Jun Wang; Kenta Masui; Andres Paucar; Huijun Yang; Minori Ohashi; Shaojun Zhu; Jill Wykosky; Rachel Reed; Stanley F Nelson; Timothy F Cloughesy; C David James; P Nagesh Rao; Harley I Kornblum; James R Heath; Webster K Cavenee; Frank B Furnari; Paul S Mischel
Journal:  Science       Date:  2013-12-05       Impact factor: 47.728

5.  Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

Authors:  Lipika Goyal; Supriya K Saha; Leah Y Liu; Giulia Siravegna; Ignaty Leshchiner; Leanne G Ahronian; Jochen K Lennerz; Phuong Vu; Vikram Deshpande; Avinash Kambadakone; Benedetta Mussolin; Stephanie Reyes; Laura Henderson; Jiaoyuan Elisabeth Sun; Emily E Van Seventer; Joseph M Gurski; Sabrina Baltschukat; Barbara Schacher-Engstler; Louise Barys; Christelle Stamm; Pascal Furet; David P Ryan; James R Stone; A John Iafrate; Gad Getz; Diana Graus Porta; Ralph Tiedt; Alberto Bardelli; Dejan Juric; Ryan B Corcoran; Nabeel Bardeesy; Andrew X Zhu
Journal:  Cancer Discov       Date:  2016-12-29       Impact factor: 39.397

6.  Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.

Authors:  Josep Tabernero; Rastislav Bahleda; Rodrigo Dienstmann; Jeffrey R Infante; Alain Mita; Antoine Italiano; Emiliano Calvo; Victor Moreno; Barbara Adamo; Anas Gazzah; Bob Zhong; Suso J Platero; Johan W Smit; Kim Stuyckens; Moitreyee Chatterjee-Kishore; Jordi Rodon; Vijay Peddareddigari; Feng R Luo; Jean-Charles Soria
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

7.  Transforming fusions of FGFR and TACC genes in human glioblastoma.

Authors:  Devendra Singh; Joseph Minhow Chan; Pietro Zoppoli; Francesco Niola; Ryan Sullivan; Angelica Castano; Eric Minwei Liu; Jonathan Reichel; Paola Porrati; Serena Pellegatta; Kunlong Qiu; Zhibo Gao; Michele Ceccarelli; Riccardo Riccardi; Daniel J Brat; Abhijit Guha; Ken Aldape; John G Golfinos; David Zagzag; Tom Mikkelsen; Gaetano Finocchiaro; Anna Lasorella; Raul Rabadan; Antonio Iavarone
Journal:  Science       Date:  2012-07-26       Impact factor: 47.728

8.  Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Authors:  Anna Luisa Di Stefano; Alessandra Fucci; Veronique Frattini; Marianne Labussiere; Karima Mokhtari; Pietro Zoppoli; Yannick Marie; Aurelie Bruno; Blandine Boisselier; Marine Giry; Julien Savatovsky; Mehdi Touat; Hayat Belaid; Aurelie Kamoun; Ahmed Idbaih; Caroline Houillier; Feng R Luo; Jean-Charles Soria; Josep Tabernero; Marica Eoli; Rosina Paterra; Stephen Yip; Kevin Petrecca; Jennifer A Chan; Gaetano Finocchiaro; Anna Lasorella; Marc Sanson; Antonio Iavarone
Journal:  Clin Cancer Res       Date:  2015-01-21       Impact factor: 13.801

9.  RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.

Authors:  Zhao-Shi Bao; Hui-Min Chen; Ming-Yu Yang; Chuan-Bao Zhang; Kai Yu; Wan-Lu Ye; Bo-Qiang Hu; Wei Yan; Wei Zhang; Johnny Akers; Valya Ramakrishnan; Jie Li; Bob Carter; Yan-Wei Liu; Hui-Min Hu; Zheng Wang; Ming-Yang Li; Kun Yao; Xiao-Guang Qiu; Chun-Sheng Kang; Yong-Ping You; Xiao-Long Fan; Wei Sonya Song; Rui-Qiang Li; Xiao-Dong Su; Clark C Chen; Tao Jiang
Journal:  Genome Res       Date:  2014-08-18       Impact factor: 9.043

10.  The landscape and therapeutic relevance of cancer-associated transcript fusions.

Authors:  K Yoshihara; Q Wang; W Torres-Garcia; S Zheng; R Vegesna; H Kim; R G W Verhaak
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.